- IBDEI21A ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32461,1,4,0)
- ;;=4^H34.8122
- ;;^UTILITY(U,$J,358.3,32461,2)
- ;;=^5138481
- ;;^UTILITY(U,$J,358.3,32462,0)
- ;;=H35.013^^128^1661^40
- ;;^UTILITY(U,$J,358.3,32462,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32462,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OU
- ;;^UTILITY(U,$J,358.3,32462,1,4,0)
- ;;=4^H35.013
- ;;^UTILITY(U,$J,358.3,32462,2)
- ;;=^5005584
- ;;^UTILITY(U,$J,358.3,32463,0)
- ;;=H35.011^^128^1661^38
- ;;^UTILITY(U,$J,358.3,32463,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32463,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OD
- ;;^UTILITY(U,$J,358.3,32463,1,4,0)
- ;;=4^H35.011
- ;;^UTILITY(U,$J,358.3,32463,2)
- ;;=^5005582
- ;;^UTILITY(U,$J,358.3,32464,0)
- ;;=H35.012^^128^1661^39
- ;;^UTILITY(U,$J,358.3,32464,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32464,1,3,0)
- ;;=3^Changes in Retinal Vascular Appearance,OS
- ;;^UTILITY(U,$J,358.3,32464,1,4,0)
- ;;=4^H35.012
- ;;^UTILITY(U,$J,358.3,32464,2)
- ;;=^5005583
- ;;^UTILITY(U,$J,358.3,32465,0)
- ;;=H35.023^^128^1661^43
- ;;^UTILITY(U,$J,358.3,32465,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32465,1,3,0)
- ;;=3^Exudative Retinopathy,OU
- ;;^UTILITY(U,$J,358.3,32465,1,4,0)
- ;;=4^H35.023
- ;;^UTILITY(U,$J,358.3,32465,2)
- ;;=^5005588
- ;;^UTILITY(U,$J,358.3,32466,0)
- ;;=H35.021^^128^1661^41
- ;;^UTILITY(U,$J,358.3,32466,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32466,1,3,0)
- ;;=3^Exudative Retinopathy,OD
- ;;^UTILITY(U,$J,358.3,32466,1,4,0)
- ;;=4^H35.021
- ;;^UTILITY(U,$J,358.3,32466,2)
- ;;=^5005586
- ;;^UTILITY(U,$J,358.3,32467,0)
- ;;=H35.022^^128^1661^42
- ;;^UTILITY(U,$J,358.3,32467,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32467,1,3,0)
- ;;=3^Exudative Retinopathy,OS
- ;;^UTILITY(U,$J,358.3,32467,1,4,0)
- ;;=4^H35.022
- ;;^UTILITY(U,$J,358.3,32467,2)
- ;;=^5005587
- ;;^UTILITY(U,$J,358.3,32468,0)
- ;;=H35.09^^128^1661^37
- ;;^UTILITY(U,$J,358.3,32468,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32468,1,3,0)
- ;;=3^Intraretinal Microvascular Abnormalities,Other
- ;;^UTILITY(U,$J,358.3,32468,1,4,0)
- ;;=4^H35.09
- ;;^UTILITY(U,$J,358.3,32468,2)
- ;;=^268617
- ;;^UTILITY(U,$J,358.3,32469,0)
- ;;=H35.23^^128^1661^46
- ;;^UTILITY(U,$J,358.3,32469,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32469,1,3,0)
- ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
- ;;^UTILITY(U,$J,358.3,32469,1,4,0)
- ;;=4^H35.23
- ;;^UTILITY(U,$J,358.3,32469,2)
- ;;=^5005645
- ;;^UTILITY(U,$J,358.3,32470,0)
- ;;=H35.21^^128^1661^44
- ;;^UTILITY(U,$J,358.3,32470,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32470,1,3,0)
- ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
- ;;^UTILITY(U,$J,358.3,32470,1,4,0)
- ;;=4^H35.21
- ;;^UTILITY(U,$J,358.3,32470,2)
- ;;=^5005643
- ;;^UTILITY(U,$J,358.3,32471,0)
- ;;=H35.22^^128^1661^45
- ;;^UTILITY(U,$J,358.3,32471,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32471,1,3,0)
- ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
- ;;^UTILITY(U,$J,358.3,32471,1,4,0)
- ;;=4^H35.22
- ;;^UTILITY(U,$J,358.3,32471,2)
- ;;=^5005644
- ;;^UTILITY(U,$J,358.3,32472,0)
- ;;=H35.043^^128^1661^30
- ;;^UTILITY(U,$J,358.3,32472,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32472,1,3,0)
- ;;=3^Retinal Micro-Aneurysms,Unspec,OU
- ;;^UTILITY(U,$J,358.3,32472,1,4,0)
- ;;=4^H35.043
- ;;^UTILITY(U,$J,358.3,32472,2)
- ;;=^5005596
- ;;^UTILITY(U,$J,358.3,32473,0)
- ;;=H35.041^^128^1661^28
- ;;^UTILITY(U,$J,358.3,32473,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32473,1,3,0)
- ;;=3^Retinal Micro-Aneurysms,Unspec,OD
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21A 3780 printed Feb 18, 2025@23:46:10 Page 2
- IBDEI21A ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32461,1,4,0)
- +2 ;;=4^H34.8122
- +3 ;;^UTILITY(U,$J,358.3,32461,2)
- +4 ;;=^5138481
- +5 ;;^UTILITY(U,$J,358.3,32462,0)
- +6 ;;=H35.013^^128^1661^40
- +7 ;;^UTILITY(U,$J,358.3,32462,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,32462,1,3,0)
- +10 ;;=3^Changes in Retinal Vascular Appearance,OU
- +11 ;;^UTILITY(U,$J,358.3,32462,1,4,0)
- +12 ;;=4^H35.013
- +13 ;;^UTILITY(U,$J,358.3,32462,2)
- +14 ;;=^5005584
- +15 ;;^UTILITY(U,$J,358.3,32463,0)
- +16 ;;=H35.011^^128^1661^38
- +17 ;;^UTILITY(U,$J,358.3,32463,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,32463,1,3,0)
- +20 ;;=3^Changes in Retinal Vascular Appearance,OD
- +21 ;;^UTILITY(U,$J,358.3,32463,1,4,0)
- +22 ;;=4^H35.011
- +23 ;;^UTILITY(U,$J,358.3,32463,2)
- +24 ;;=^5005582
- +25 ;;^UTILITY(U,$J,358.3,32464,0)
- +26 ;;=H35.012^^128^1661^39
- +27 ;;^UTILITY(U,$J,358.3,32464,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,32464,1,3,0)
- +30 ;;=3^Changes in Retinal Vascular Appearance,OS
- +31 ;;^UTILITY(U,$J,358.3,32464,1,4,0)
- +32 ;;=4^H35.012
- +33 ;;^UTILITY(U,$J,358.3,32464,2)
- +34 ;;=^5005583
- +35 ;;^UTILITY(U,$J,358.3,32465,0)
- +36 ;;=H35.023^^128^1661^43
- +37 ;;^UTILITY(U,$J,358.3,32465,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,32465,1,3,0)
- +40 ;;=3^Exudative Retinopathy,OU
- +41 ;;^UTILITY(U,$J,358.3,32465,1,4,0)
- +42 ;;=4^H35.023
- +43 ;;^UTILITY(U,$J,358.3,32465,2)
- +44 ;;=^5005588
- +45 ;;^UTILITY(U,$J,358.3,32466,0)
- +46 ;;=H35.021^^128^1661^41
- +47 ;;^UTILITY(U,$J,358.3,32466,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,32466,1,3,0)
- +50 ;;=3^Exudative Retinopathy,OD
- +51 ;;^UTILITY(U,$J,358.3,32466,1,4,0)
- +52 ;;=4^H35.021
- +53 ;;^UTILITY(U,$J,358.3,32466,2)
- +54 ;;=^5005586
- +55 ;;^UTILITY(U,$J,358.3,32467,0)
- +56 ;;=H35.022^^128^1661^42
- +57 ;;^UTILITY(U,$J,358.3,32467,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,32467,1,3,0)
- +60 ;;=3^Exudative Retinopathy,OS
- +61 ;;^UTILITY(U,$J,358.3,32467,1,4,0)
- +62 ;;=4^H35.022
- +63 ;;^UTILITY(U,$J,358.3,32467,2)
- +64 ;;=^5005587
- +65 ;;^UTILITY(U,$J,358.3,32468,0)
- +66 ;;=H35.09^^128^1661^37
- +67 ;;^UTILITY(U,$J,358.3,32468,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,32468,1,3,0)
- +70 ;;=3^Intraretinal Microvascular Abnormalities,Other
- +71 ;;^UTILITY(U,$J,358.3,32468,1,4,0)
- +72 ;;=4^H35.09
- +73 ;;^UTILITY(U,$J,358.3,32468,2)
- +74 ;;=^268617
- +75 ;;^UTILITY(U,$J,358.3,32469,0)
- +76 ;;=H35.23^^128^1661^46
- +77 ;;^UTILITY(U,$J,358.3,32469,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,32469,1,3,0)
- +80 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
- +81 ;;^UTILITY(U,$J,358.3,32469,1,4,0)
- +82 ;;=4^H35.23
- +83 ;;^UTILITY(U,$J,358.3,32469,2)
- +84 ;;=^5005645
- +85 ;;^UTILITY(U,$J,358.3,32470,0)
- +86 ;;=H35.21^^128^1661^44
- +87 ;;^UTILITY(U,$J,358.3,32470,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,32470,1,3,0)
- +90 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
- +91 ;;^UTILITY(U,$J,358.3,32470,1,4,0)
- +92 ;;=4^H35.21
- +93 ;;^UTILITY(U,$J,358.3,32470,2)
- +94 ;;=^5005643
- +95 ;;^UTILITY(U,$J,358.3,32471,0)
- +96 ;;=H35.22^^128^1661^45
- +97 ;;^UTILITY(U,$J,358.3,32471,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,32471,1,3,0)
- +100 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
- +101 ;;^UTILITY(U,$J,358.3,32471,1,4,0)
- +102 ;;=4^H35.22
- +103 ;;^UTILITY(U,$J,358.3,32471,2)
- +104 ;;=^5005644
- +105 ;;^UTILITY(U,$J,358.3,32472,0)
- +106 ;;=H35.043^^128^1661^30
- +107 ;;^UTILITY(U,$J,358.3,32472,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,32472,1,3,0)
- +110 ;;=3^Retinal Micro-Aneurysms,Unspec,OU
- +111 ;;^UTILITY(U,$J,358.3,32472,1,4,0)
- +112 ;;=4^H35.043
- +113 ;;^UTILITY(U,$J,358.3,32472,2)
- +114 ;;=^5005596
- +115 ;;^UTILITY(U,$J,358.3,32473,0)
- +116 ;;=H35.041^^128^1661^28
- +117 ;;^UTILITY(U,$J,358.3,32473,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,32473,1,3,0)
- +120 ;;=3^Retinal Micro-Aneurysms,Unspec,OD
